Acetylcholinesterase inhibitors attenuate atherogenesis in apolipoprotein E-knockout mice
Authors:
- Toshihiro IchikiTIToshihiro Ichiki
- Ryohei MiyazakiRMRyohei Miyazaki
- Kotaro TakedaKTKotaro Takeda
- Toru HashimotoTHToru Hashimoto
- Hirohide MatsuuraHMHirohide Matsuura
- Kenji SunagawaKSKenji Sunagawa
- 1 November 2010
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 213 (1) , 52-58
Abstract
No abstract availableKeywords
Funding Information
- Astellas Foundation for Research on Metabolic Disorders
- AstraZeneca
- Suzuken Memorial Foundation
- Ministry of Education, Culture, Sports, Science and Technology (19590867)
This publication has 28 references indexed in Scilit:
- Anti-Alzheimer's Drug, Donepezil, Markedly Improves Long-Term Survival After Chronic Heart Failure in MiceJournal of Cardiac Failure, 2009
- NADPH oxidases and angiotensin II receptor signalingMolecular and Cellular Endocrinology, 2009
- A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2008
- Inhaled Anticholinergics and Risk of Major Adverse Cardiovascular Events in Patients With Chronic Obstructive Pulmonary DiseaseJAMA, 2008
- Modulation of the myocardial redox state by vagal nerve stimulation after experimental myocardial infarctionCardiovascular Research, 2007
- Acetylcholinesterase inhibitors effects on oncostatin-M, interleukin-1? and interleukin-6 release from lymphocytes of Alzheimer's disease patientsExperimental Gerontology, 2005
- Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammationNature, 2002
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- ATRAMI: a mark in the quest for the prognostic value of autonomic markersEuropean Heart Journal, 1998
- The cholinergic innervation, of the aortaActa Histochemica, 1980